{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:17:13Z","timestamp":1772608633321,"version":"3.50.1"},"reference-count":33,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Delivery"],"published-print":{"date-parts":[[2025,5,4]]},"DOI":"10.1080\/20415990.2025.2477440","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:05:35Z","timestamp":1742861135000},"page":"419-429","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Novel nanostructured lipid carriers with lurasidone hydrochloride for intranasal administration for improved bioavailability"],"prefix":"10.1080","volume":"16","author":[{"given":"Tanvi","family":"Kadam","sequence":"first","affiliation":[{"name":"SVKM\u2019s NMIMS","place":["Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Datta Meghe Institute of Medical Sciences (Deemed to be University)","place":["Wardha, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2440-5398","authenticated-orcid":false,"given":"Saritha","family":"Shetty","sequence":"additional","affiliation":[{"name":"SVKM\u2019s NMIMS","place":["Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61680-8"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14com09571"},{"issue":"12","key":"e_1_3_6_5_1","first-page":"832","article-title":"Newer oral atypical antipsychotic agents: a review","volume":"36","author":"Scarff J","year":"2011","unstructured":"Scarff J, Casey D. Newer oral atypical antipsychotic agents: a review. Pharm Ther. 2011;36(12):832\u2013838.","journal-title":"Pharm Ther"},{"issue":"9","key":"e_1_3_6_6_1","first-page":"638","article-title":"Schizophrenia: overview and treatment options","volume":"39","author":"Patel K","year":"2014","unstructured":"Patel K, Cherian J, Gohil K, et al. Schizophrenia: overview and treatment options. Phar Therap. 2014;39(9):638\u2013645.","journal-title":"Phar Therap"},{"issue":"3","key":"e_1_3_6_7_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stoup S","year":"2018","unstructured":"Stoup S, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018;17(3):341\u2013356.","journal-title":"World Psychiatry"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61611-6"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02810-0"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-012-0052-6"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0465-5"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2011.603388"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.3651"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2015.07.002"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.03.029"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040831"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1046660"},{"key":"e_1_3_6_18_1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert W","year":"2012","unstructured":"Mehnert W, M\u00e4der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2012;47:165\u2013196.","journal-title":"Adv Drug Deliv Rev"},{"key":"e_1_3_6_19_1","unstructured":"ICH Q2 (R2). Pharmaceutical development. 2009 Aug. Available from: <http:\/\/www.fda.gov\/downloads\/Drugs\/\u2026\/Guidances\/ucm073511.pdf>"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.07.043"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2014.975382"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2009.11.006"},{"key":"e_1_3_6_23_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-12-818433-2.00002-9","volume-title":"Materials for biomedical engineering","author":"Babu VN","year":"2019","unstructured":"Babu VN, Vivek R, Rejeeth C, et al. Polymeric nanomaterial revolution in drug delivery systems: toward patient care. In: Materials for biomedical engineering. Elsevier; 2019 Jan 1. p. 33\u201358."},{"key":"e_1_3_6_24_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(97)00186-5","article-title":"Preparation and evaluation of acetazolamide liposomes as an ocular delivery system","volume":"158","author":"OEl-Gazayerly ON","year":"1997","unstructured":"OEl-Gazayerly ON, Hikal AH. Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharm. 1997;158:121\u2013127.","journal-title":"Int J Pharm"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1006\/jcis.2002.8399"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2006.05.010"},{"issue":"4","key":"e_1_3_6_27_1","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3390\/ijms21041262","article-title":"Topical drug delivery systems based on bacterial nanocellulose: accelerated stability testing","volume":"21","author":"Silva N","year":"2020","unstructured":"Silva N, Mota J, Almeida T, et al. Topical drug delivery systems based on bacterial nanocellulose: accelerated stability testing. Int J Mol Sci. 2020;21(4):2462.","journal-title":"Int J Mol Sci"},{"issue":"225","key":"e_1_3_6_28_1","first-page":"1","article-title":"Development of novel pH-sensitive nanoparticles loaded hydrogel for transdermal drug delivery","volume":"45","author":"Qaindeel M","year":"2019","unstructured":"Qaindeel M, Ahmed N, Sabir F, et al. Development of novel pH-sensitive nanoparticles loaded hydrogel for transdermal drug delivery. Drug Dev Ind Pharm. 2019;45(225):1\u201329.","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"e_1_3_6_29_1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/2230-973X.153390","article-title":"Solubility enhancement studies on lurasidone hydrochloride using mixed hydrotropy","volume":"5","author":"Madan JR","year":"2015","unstructured":"Madan JR, Pawar KT, Dua K. Solubility enhancement studies on lurasidone hydrochloride using mixed hydrotropy. Int J Pharm Investigation. 2015 Apr;5(2):114.","journal-title":"Int J Pharm Investigation"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-009-9197-2"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2017.09.022"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/1385772X.2012.688328"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/340315"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12111098"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.07.025"}],"container-title":["Therapeutic Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20415990.2025.2477440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T10:54:21Z","timestamp":1746096861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20415990.2025.2477440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,4]]}},"alternative-id":["10.1080\/20415990.2025.2477440"],"URL":"https:\/\/doi.org\/10.1080\/20415990.2025.2477440","relation":{},"ISSN":["2041-5990","2041-6008"],"issn-type":[{"value":"2041-5990","type":"print"},{"value":"2041-6008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}